BeiGene Net Worth 2014-2024 | ONC

Interactive chart of historical net worth (market cap) for BeiGene (ONC) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. BeiGene net worth as of January 03, 2025 is $17.96B.
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $17.962B $2.459B
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Heidelberg Materials AG (HDLMY) Germany $22.212B 0.00
BrightSphere Investment Group (AAMI) United States $0.962B 11.46
Viad Corp (PRSU) United States $0.883B 39.27
Westaim (WEDXD) Canada $0.461B 12.39
Coliseum Acquisition (RAIN) United States $0.040B 0.00
ILearningEngines (AILEQ) United States $0.000B 0.00